Biotech

The entrepreneur is widely known for his aggressive pursuit of eternal youth through 'Project Blueprint,' an anti-aging program he claims costs him over Rs 17 crore annually.

China’s biotech moment ignites a 60% stock rally that beats AI

The surge in China-listed biotech firms is further evidence that the mainland is becoming a center for global innovation

Amgen opens new technology & innovation site in Hyderabad, to invest $200 million

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further advance its pipeline of medicines, while creating significant opportunities for local talent.

US BioSecure Act: Impact on India and biotech opportunities in supply chain shifts

The BioSecure Act seeks to reduce US-China biotech ties, creating potential for India to become a biomanufacturing hub. However, India's biotech sector must overcome challenges in innovation, regulatory standards, and technology to attract businesses shifting from China.

There is no real ecosystem for deep tech in India: Accel’s Prashanth Prakash

Prakash’s comments come at a time when deep tech innovations in India are on the rise and are attracting investments from venture capital (VC) and private equity (PE) firms.

Agritech startup Loopworm raises $3.4 million in seed funding led by Omnivore, WaterBridge

Loopworm, in a statement, said it plans to use the seed funding for talent acquisition, research and development (R&D) including building laboratories, and to launch its first factory in North Bengaluru for scaling up production.

Praj Industries will grow at 30-40%, keen to expand in biochemicals, sustainable ATF: Pramod Chaudhari, Chairman

"We can operate in the range of 30-40 percent growth, I can say that with reasonable confidence, given huge thrust on energy transition and climate action," said Pramod Chaudhari, Chairman, Praj Industries.

U.S. FDA advisers back COVID vaccines for children as young as 6 months

On Wednesday, a panel of FDA advisers unanimously recommended that the agency approve COVID-19 vaccinations from Moderna Inc and Pfizer Inc/BioNTech SE for millions of youngsters in the United States.

India's bio-economy has grown 8 times in the past 8 years to $80 billion: PM at Biotech Startup Expo

Modi also launched the biotech showcase portal, which parades 750 indigenous products and technologies from the biotech sector

Ideal time for booster dose for COVID vaccine is 6 months after 2nd dose: Bharat Biotech MD Krishna Ella

The ideal time for a booster dose is six months after the second dose," Ella stated. ”The ideal time for a booster dose is six months after the second dose,” Ella stated. Bharat Biotech is also looking at nasal vaccine as a booster dose as its scaling up capacity is very easy when compared with Covaxin, he added.

Laurus Labs: Diversification to speed up in FY23; add on declines

There is a perceptible change in the Laurus Labs' management commentary in the last 18 months that points to growth sustenance for the medium term

Laurus Labs: Foray into biotech adds new lever of growth; accumulate

Efforts to diversify will open up new opportunities for Laurus Labs and make it move towards a higher-margin trajectory

Atmanirbhar Bharat provides vision of India's plans to become USD 5 trillion economy: MEA official

MEA Secretary (CPV&OIA) Sanjay Bhattacharyya said new emerging technologies, especially in ICT, consultancy, fin-tech, logistics, edutech, healthtech, biotech.

Inside India’s genetic crop battlefield

By resisting GM technology in farming, India risks falling behind the rest of the world on crop yields, shelf life

ITC's agri-biotech arm inks pact with UK's James Hutton to source new potatoes varieties

"These differentiated varieties promise to further benefit India's farmers and the potato processing industry as well as help in promoting potato exports. The agreement is initially for a period of five years and is extendable," ITC said in a statement.

Biocon to see inspections by USFDA & EMA in April-May: Sources

Biotech company, Biocon will see two crucial inspections later this month and in early April. Company‘s manufacturing sites will come up for inspections by the European medicines agency later this month and next will be an inspection by the US FDA.

Trump says pharma companies are 'getting away with murder

US President-elect Donald Trump on Wednesday said pharmaceutical companies are "getting away with murder" in the prices that they charge the government for medicines, and promised that would change.

Bayer launches open offer to buy up to 26% in Monsanto India

In the open offer, Bayer will acquire up to 44,88,315 shares of Monsanto India Ltd from public shareholders at a price of Rs 2,481.60 apiece.

Cuba evinces interest in economic cooperation with India

Cuba is "interested" in cooperation in some spheres of Indian economy, including renewable energy, biotech, pharmaceutical, information technology and software.

Expect 20% growth in FY16: RPG Life Sciences

Speaking to CNBC-TV18, CT Renganathan, MD of the company said that new launches aided domestic growth. Both international business and biotech space have performed well in the Q3, he said.

India risk missing boat as biosimilars shake up drug sector

While Indian firms have launched a few such products on the domestic market, where regulatory barriers are relatively low, they are being overtaken by European, American and South Korean firms in the race to supply lucrative Western markets.

PE funds bet big on India, pour USD 7 bn in H1

While the M&A opportunities remain robust, especially when there are companies on the block with high level of leverage, enhanced interest by the private equity players remains a noteworthy point.

Drugmaker Shire bids $30 bn for Baxter spin-off Baxalta

Drugmaker Shire said on Tuesday it was seeking to buy Baxalta a company spun-off by Baxter International last month, for USD 30 billion to forge the leading global specialist in rare diseases.

BioAsia 2014: A holistic approach to product innovation

Companies from across the globe come together to pull in ideas and resources for sustainable and viable biotech innovations. It may sound technical, but CNBC-TV18 learnt that it is very relevant to our growing healthcare needs.

India's agri-biotech cliff

India's Agri-Biotech Cliff